Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project.
Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project.
复制标题
DOI:
10.5888/pcd9.110311
复制
发表时间:
2012
影响因子:
5.5
通讯作者:
SUPREME-DM Study Group
中科院分区:
文献类型:
--
作者:
Nichols GA;Desai J;Elston Lafata J;Lawrence JM;O'Connor PJ;Pathak RD;Raebel MA;Reid RJ;Selby JV;Silverman BG;Steiner JF;Stewart WF;Vupputuri S;Waitzfelder B;SUPREME-DM Study Group
Electronic health record (EHR) data enhance opportunities for conducting surveillance of diabetes. The objective of this study was to identify the number of people with diabetes from a diabetes DataLink developed as part of the SUPREME-DM (SUrveillance, PREvention, and ManagEment of Diabetes Mellitus) project, a consortium of 11 integrated health systems that use comprehensive EHR data for research. We identified all members of 11 health care systems who had any enrollment from January 2005 through December 2009. For these members, we searched inpatient and outpatient diagnosis codes, laboratory test results, and pharmaceutical dispensings from January 2000 through December 2009 to create indicator variables that could potentially identify a person with diabetes. Using this information, we estimated the number of people with diabetes and among them, the number of incident cases, defined as indication of diabetes after at least 2 years of continuous health system enrollment. The 11 health systems contributed 15,765,529 unique members, of whom 1,085,947 (6.9%) met 1 or more study criteria for diabetes. The nonstandardized proportion meeting study criteria for diabetes ranged from 4.2% to 12.4% across sites. Most members with diabetes (88%) met multiple criteria. Of the members with diabetes, 428,349 (39.4%) were incident cases. The SUPREME-DM DataLink is a unique resource that provides an opportunity to conduct comparative effectiveness research, epidemiologic surveillance including longitudinal analyses, and population-based care management studies of people with diabetes. It also provides a useful data source for pragmatic clinical trials of prevention or treatment interventions.
登录
查看更多内容
影响因子:
2.8
作者:
Harris SB;Glazier RH;Tompkins JW;Wilton AS;Chevendra V;Stewart MA;Thind A
通讯作者:
Thind A
影响因子:
7.2
作者:
Newton, KM;Wagner, EH;Davis, C
通讯作者:
Davis, C
影响因子:
4
作者:
Asghari, Shabnam;Courteau, Josiane;Vanasse, Alain
通讯作者:
Vanasse, Alain
DOI:
10.1177/106286069901400607
发表时间:
1999-11-01
期刊:
American journal of medical quality : the official journal of the American College of Medical Quality
影响因子:
--
作者:
Hebert, P L;Geiss, L S;McBean, A M
通讯作者:
McBean, A M
影响因子:
16.2
作者:
Cowie CC;Rust KF;Ford ES;Eberhardt MS;Byrd-Holt DD;Li C;Williams DE;Gregg EW;Bainbridge KE;Saydah SH;Geiss LS
通讯作者:
Geiss LS